Walmart's guidance is the more honest signal than its blowout quarter

Walmart posted $177.8 billion in Q1 revenue with e-commerce up 26%, but the company's warning of a full-year growth slowdown tied to macroeconomic pressure is what moved the stock.

A retailer of Walmart's scale doesn't guide conservatively by accident, and the gap between a blowout quarter and a cautious outlook is exactly the kind of signal the market reads as a ceiling, not a floor.

Gilead's back-to-back regulatory wins signal a pipeline that is finally delivering

Gilead Sciences secured FDA approval for Hepcludex as the first U.S. treatment for chronic hepatitis D, and separately won a European backing for Trodelvy in triple-negative breast cancer, two meaningful label expansions in a single day.

For a company that has long been defined by its hepatitis C franchise, landing in two new disease areas simultaneously is the kind of diversification that changes how analysts model its long-term revenue ceiling.

The market punished BJ's Wholesale despite a clean beat on every metric

BJ's Wholesale Club reported Q1 revenues up 10%, record membership fee income, and 28% digital comparable sales growth, yet a sharp single-session selloff followed a quarter with no obvious miss.

When a clean beat produces a sharp selloff, the story is almost never about the quarter itself but about what the guidance implies for the growth rate investors had already priced in.